Valuation: ICON Public Limited Company

Capitalization 8.83B 7.49B 6.92B 6.52B 12.1B 821B 12.31B 81.11B 31.79B 395B 33.11B 32.42B 1,405B P/E ratio 2025 *
17.9x
P/E ratio 2026 * 14.1x
Enterprise value 11.69B 9.93B 9.17B 8.64B 16.03B 1,088B 16.31B 107B 42.11B 523B 43.86B 42.94B 1,861B EV / Sales 2025 *
1.45x
EV / Sales 2026 * 1.38x
Free-Float
99.29%
Yield 2025 *
-
Yield 2026 * -
1 day-0.79%
1 week+8.32%
Current month+4.45%
1 month+18.41%
3 months-36.71%
6 months-38.67%
Current year-36.57%
1 week 105.05
Extreme 105.05
118.54
1 month 95.75
Extreme 95.75
118.54
Current year 66.57
Extreme 66.57
203.91
1 year 66.57
Extreme 66.57
211
3 years 66.57
Extreme 66.57
347.72
5 years 66.57
Extreme 66.57
347.72
10 years 62.31
Extreme 62.31
347.72
Manager TitleAgeSince
Director of Finance/CFO 53 2024-09-30
Chief Tech/Sci/R&D Officer - -
Chief Administrative Officer 51 2016-06-30
Director TitleAgeSince
Chairman 73 2002-10-31
Chairman 63 2017-02-28
Director/Board Member 65 2015-11-24
Change 5d. change 1-year change 3-years change Capi.($)
-0.79%+8.32%-19.48%-44.90% 8.9B
-0.41%+5.02%-1.85%-9.41% 47.73B
+0.24%+2.32%+40.57%+21.48% 35.48B
-2.14%+55.13%+312.35%+574.21% 30.23B
-3.45%+1.76%+15.84%-14.18% 29.9B
+3.47%+3.72%+36.62%+29.82% 28.75B
+0.51%+0.51%+53.62%+199.31% 14.93B
-0.56%+2.82%+73.91%+168.37% 14.81B
+2.55%+8.52%+4,163.00%+4,049.02% 14.74B
-0.29%+8.19%+37.00%+11.64% 14.42B
Average -0.09%+9.86%+471.16%+498.54% 23.99B
Weighted average by Cap. -0.22%+10.77%+316.56%+346.11%

Financials

2025 *2026 *
Net sales 8.05B 6.83B 6.31B 5.95B 11.04B 749B 11.23B 73.96B 28.99B 360B 30.19B 29.56B 1,281B 7.97B 6.77B 6.25B 5.89B 10.93B 742B 11.12B 73.26B 28.71B 357B 29.9B 29.28B 1,269B
Net income 532M 451M 417M 393M 729M 49.46B 742M 4.88B 1.91B 23.79B 1.99B 1.95B 84.6B 547M 464M 429M 404M 749M 50.85B 762M 5.02B 1.97B 24.47B 2.05B 2.01B 86.99B
Net Debt 2.87B 2.43B 2.25B 2.12B 3.93B 267B 4B 26.33B 10.32B 128B 10.75B 10.52B 456B 2.16B 1.84B 1.7B 1.6B 2.97B 201B 3.02B 19.88B 7.79B 96.86B 8.12B 7.95B 344B
Logo ICON Public Limited Company
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Employees
39,800
Date Price Change Volume
26-04-16 115.58 $ -0.79% 1,139,194
26-04-15 116.50 $ +3.04% 1,356,758
26-04-14 113.06 $ +2.44% 899,386
26-04-13 110.37 $ +3.33% 951,128
26-04-10 106.81 $ +0.10% 669,617
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
115.58USD
Average target price
132.08USD
Spread / Average Target
+14.27%

Quarterly revenue - Rate of surprise